Conference Coverage

High CV risk factor burden in young adults a ‘smoldering’ crisis


 

FROM ACC 2023

Double down on screening

Dr. Wadhera said “we need to double down on efforts to screen for and treat cardiovascular risk factors like high blood pressure and diabetes in young adults. We need to intensify clinical and public health interventions focused on primordial and primary prevention in young adults now so that we can avoid a tsunami of cardiovascular disease in the long term.”

“It’s critically important that young adults speak with their health care provider about whether – and when – they should undergo screening for high blood pressure, diabetes, and high cholesterol,” Dr. Wadhera added.

Dr. Berger said one problem is that younger people often have a “superman or superwoman” view and don’t comprehend that they are at risk for some of these conditions. Studies such as this “reinforce the idea that it’s never too young to be checked out.”

As a cardiologist who specializes in cardiovascular prevention, Dr. Berger said he sometimes hears patients say things like, “I don’t ever want to need a cardiologist,” or “I hope I never need a cardiologist.”

“My response is, ‘There are many different types of cardiologists,’ and I think it would really be helpful for many people to see a prevention-focused cardiologist way before they have problems,” he said in an interview.

“As a system, medicine has become very good at treating patients with different diseases. I think we need to get better in terms of preventing some of these problems,” Dr. Berger added.

In their editorial, Dr. Allen and Dr. Wilkins say the “foundation of cardiovascular health begins early in life. These worsening trends in risk factors highlight the importance of focusing on prevention in adolescence and young adulthood in order to promote cardiovascular health across the lifetime.”

The study was funded by a grant from the National Heart, Lung, and Blood Institute. Dr. Wadhera has served as a consultant for Abbott and CVS Health. Dr. Wilkins has received personal fees from 3M. Dr. Berger has disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Persistent gaps in drug use by patients with type 2 diabetes
MDedge Cardiology
Keto for life? Reasons to think twice
MDedge Cardiology
Meta-analysis throws more shade aspirin’s way
MDedge Cardiology
New ACC, AHA, SCAI interventional cardiology training guidance
MDedge Cardiology
New AHA statement urges focus on CV risk before pregnancy
MDedge Cardiology
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
MDedge Cardiology
NUDGE-FLU: Electronic ‘nudges’ boost flu shot uptake in seniors
MDedge Cardiology
Causal AI quantifies CV risk, providing patient-specific goals
MDedge Cardiology
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD
MDedge Cardiology
Biomarkers linked to elevated T2D MACE risk in DECLARE-TIMI 58
MDedge Cardiology